Reconstituted viral envelopes--'Trojan horses' for drug delivery and gene therapy?
Reconstituted viral envelopes (RVEs) are formed by solubilizing intact virus in detergent and reassembling the envelope on removal of detergent. RVEs can be formed in the presence of agents that become encapsulated and can then be utilized in vitro and in vivo for drug delivery, cell destruction, transfer of membrane components, and as vectors for genetic engineering. The problems with biotechnological applications of RVEs and possible strategies for overcoming them are discussed in this article.
Blumenthal
R
R
Section on Membrane Structure and Function, LMMB, NCI, National Institutes of Health, Bethesda, MD 20892.
Loyter
A
A
D000818:Animals; D004337:Drug Carriers; D015316:Genetic Therapy; D006801:Humans; D012995:Solubility; D014759:Viral Envelope Proteins / Q000627:therapeutic use
D004337:Drug Carriers; D014759:Viral Envelope Proteins